Novo Nordisk strikes deal worth up to $1.1 billion to expand cardio business
Denmark's Novo Nordisk said on Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen its cardiovascular pipeline.
Novo Nordisk in asian news
Novo Nordisk's Wegovy weight loss drug approved in China
Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world's second largest economy.
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies.
Weight loss drug contender Zealand Pharma jumps 18% on trial results
LONDON — Shares of Denmark's Zealand Pharma popped on Friday, notching a record high after an early-stage study of its weight loss drug challenger produced positive results.
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime.
Cigna will cap how much insurance can spend on weight loss drugs as it tries to expand coverage
Cigna on Thursday said it will limit how much health plans and employers spend on weight loss drugs each year in a bid to expand insurance coverage for those highly popular treatments.
Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug results
Shares of Denmark's Zealand Pharma rocketed higher, after the company posted strong results from a trial of a liver disease treatment that has been touted as a potential competitor in the booming weight loss drug market.